$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies
ImmunoPrecise Antibodies Hosts TECHDAY on AI Innovations
ImmunoPrecise Highlights Publication Of Mayo Clinic Scientist-Led Research In BioRxiv And Autophagy Titled 'Development and Characterization of Phospho-Ubiquitin Antibodies to Monitor PINK1-PRKN Signaling in Cells and Tissue'
ImmunoPrecise Advances Anti-Aging Research With Mayo Clinic Study, Poised to Tap Into $81 Billion Market With AI Technology
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design